Open Access
Planta Medica International Open 2016; 3(02): e47-e50
DOI: 10.1055/s-0042-109070
Letter
Georg Thieme Verlag KG Stuttgart · New York

Cytotoxic New Nortriterpene from Roots of Potentilla atrosanguinea var. argyrophylla and its UPLC Quantification

Mayanka Walia
1   Academy of Scientific and Innovative Research, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
2   Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
,
Dharmesh Kumar
3   Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
,
Pawan Kumar
2   Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
,
Bikram Singh
1   Academy of Scientific and Innovative Research, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
2   Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
,
Yogendra S. Padwad
3   Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
,
Vijai K. Agnihotri
1   Academy of Scientific and Innovative Research, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
2   Natural Product Chemistry and Process Development Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh, India
› Author Affiliations
Further Information

Publication History

received 17 February 2016
revised 20 April 2016

accepted 16 May 2016

Publication Date:
15 August 2016 (online)

Preview

Abstract

Potentilla atrosanguinea is well known for its ethnomedicinal uses since ancient times. The present study includes the isolation of a new nortriterpene, 28-methyl-acanthochlamate (1), from the roots of P. atrosanguinea. The structure of 1 was established from HR-ESI-MS and NMR spectroscopic analysis. Its relative stereochemistry was set with the help of NOESY correlation experiment. Compound (1) has been quantified by a new developed UPLC-DAD method (1.1 mg/g). The in vitro cytotoxicity of the new compound (1) was evaluated by sulforhodamine B assay against three cancer cells; human cervical cancer (SiHa), epidermal carcinoma (KB), and human adenocarcinoma (Colo-205). The new isolated compound (1) showed a significantly higher cytotoxicity against all the cells (SiHa, IC50 30.5 µg/mL; KB, IC50 22.6 µg/mL and Colo-205, IC50 18.8 µg/mL).

Supporting Information